Yes

Date 07 May 2017
Event ELCC 2017
Session Is there a role for second-line immunotherapy in patients with PD-L1 negative NSCLC?
Topics Immunotherapy
Thoracic Malignancies
Therapy
Presenter Roy Herbst
Authors R. Herbst
  • Yale School of Medicine, 06520 - New Haven, CT/US